Viking Therapeutics Inc (VKTX)

[Titan V]

I see VKTX repeating MRNS story. They did an offering at $3.75 and started trading above $4 the following day, slowly rising to where it is now before data next month. Their offering was led by Bain Capital. Viking seems to have attracted that institutional interest after MDGL data. I think the next few months will see some steady rise.

———

PS. I know this is frowned upon but I see MRNS seeing a big upwards correction on ppd p2 data in Jan. Their benchmark is SAGE (similar drugs, same indication) so may be worth looking into. GL all. 2018 is going to be a good year for us.